Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: I
Results 151 - 160 of 403 shown below

  • in vitro-to-in vivo correlations

    J I Johnson, S Decker, D Zaharevitz, L V Rubinstein, J M Venditti, S Schepartz, S Kalyandrug, M Christian, S Arbuck, M Hollingshead and E A Sausville

    Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

    doi:10.1054/bjoc.2001.1796

    Abstract | Full article | PDF

  • in vivo

    R Kuefer, M D Hofer, V Altug, C Zorn, F Genze, K Kunzi-Rapp, R E Hautmann and J E Gschwend

    Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer

    doi:10.1038/sj.bjc.6601510

    Abstract | Full article | PDF

  • P Lagadec, E Griessinger, M P Nawrot, N Fenouille, P Colosetti, V Imbert, M Mari, P Hofman, D Czerucka, D Rousseau, E Berard, M Dreano and J F Peyron

    Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells

    advance online publication, 2008-01-08 00:00:00.000;

    doi:10.1038/sj.bjc.6604082

    Abstract | Full article | PDF

  • C J F Van Noorden, T G N Jonges, L C Meade-Tollin, R E Smith and A Koehler

    In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants

    doi:10.1054/bjoc.1999.1021

    Abstract | Full article | PDF

  • L H Patterson and S R McKeown

    AQ4N: a new approach to hypoxia-activated cancer chemotherapy

    doi:10.1054/bjoc.2000.1564

    Abstract | Full article | PDF

  • in vivo animal models

    S Hazama, T Noma, F Wang, N Iizuka, Y Ogura, K Yoshimura, E Inoguchi, M Hakozaki, K Hirose, T Suzuki and M Oka

    Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo

    doi:10.1038/sj.bjc.6690538

    Abstract | Full article | PDF

  • in vivo cancer chemotherapy

    A Kruczynski, C Etiévant, D Perrin, T Imbert, F Colpaert and B T Hill

    Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases

    doi:10.1054/bjoc.2000.1428

    Abstract | Full article | PDF

  • in vivo electropermeabilization

    H Mekid, O Tounekti, A Spatz, M Cemazar, F Z El Kebir and L M Mir

    In vivo evolution of tumour cells after the generation of double-strand DNA breaks

    doi:10.1038/sj.bjc.6600959

    Abstract | Full article | PDF

  • in vivo elimination

    T B Christensen, J Marqversen, F Engbaek, P Berger, T Bacher and H von der Maase

    Validation of 125I-hCG as a marker for elimination of hCG and stability of 125I-hCG after in vivo injection in humans

    doi:10.1038/sj.bjc.6690566

    Abstract | Full article | PDF

  • in vivo expression

    K-J J Cheung, J A Bush, W Jia and G Li

    Expression of the novel tumour suppressor p33ING1 is independent of p53

    doi:10.1054/bjoc.2000.1464

    Abstract | Full article | PDF

  • in vivo imaging

    D Yoshikawa, H Ojima, A Kokubu, T Ochiya, S Kasai, S Hirohashi and T Shibata

    Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma

    advance online publication, 2009-03-24 00:00:00.000;

    doi:10.1038/sj.bjc.6604988

    Abstract | Full article | PDF

  • in vivo microscopy

    E A te Velde, A Reijerkerk, D Brandsma, J M Vogten, Y Wu, O Kranenburg, E E Voest, M Gebbink and I H M Borel Rinkes

    Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells

    advance online publication, 2005-02-08 00:00:00.000;

    doi:10.1038/sj.bjc.6602385

    Abstract | Full article | PDF

  • in-house cDNA microarray

    K Shimada, K Uzawa, M Kato, Y Endo, M Shiiba, H Bukawa, H Yokoe, N Seki and H Tanzawa

    Aberrant expression of RAB1A in human tongue cancer

    advance online publication, 2005-05-03 00:00:00.000;

    doi:10.1038/sj.bjc.6602594

    Abstract | Full article | PDF